The evolving AI landscape in life sciences in 2026: AI-ready data, agents, and semantic technologies

The generative AI story in life sciences is evolving fast. We're all familiar with genAI as chat interfaces. useful, but passive. The real frontier is the virtual researcher, an AI that works alongside scientists as a colleague, combining the reasoning speed of an agent with the judgment and domain expertise of a human. This theme explores where we are on that journey, what's real today, and what it takes to get there.

Garbage in, garbage out is not a new principle, but it hits differently when AI agents are autonomously making decisions across your data landscape. Most life sciences organizations sit on vast but fragmented assets: disconnected silos of clinical, omics, and literature data that LLMs simply cannot reason over reliably. This theme tackles what AI-ready data really means in practice: ontologies, knowledge graphs, and FAIR data principles as the structured backbone that agentic AI requires to act trustworthily.

Life sciences organizations deal with dozens of disconnected data sources. The real breakthroughs happen when you can explore and query across all of them as if they were one. This theme explores how semantic technologies and knowledge graphs make unified exploration possible: enabling researchers to discover hidden connections, accelerate target validation, and build a continuously evolving picture of their data landscape, without needing to know where each piece of data lives.

None of it gets deployed if the organization can't trust it. In this sector, trust isn't optional, regulators, clinicians, and patients all demand explainability, auditability, and accountability. This theme confronts the hard questions: how do you build confidence in genAI outputs across the drug development lifecycle, ensure source provenance when decisions are based on AI-generated insights, and balance innovation velocity with the rigorous data governance frameworks that regulated industries require?